What is endotoxin testing and when is pyrogen control required?

Beyond Biopharma | Pharmaceutical Gelatin FAQ

Short answer: Endotoxin testing measures bacterial endotoxin, a type of pyrogen that can cause fever if it enters the bloodstream, typically with the Limulus amoebocyte lysate (LAL) test or a comparable current method. Pyrogen control is required only in specific contexts, mainly where gelatin or a gelatin-derived material is intended for injectables, vaccines, biologics or other sterile applications; gelatin for conventional oral capsules and tablets is normally not controlled for endotoxin, and the applicable requirement is always defined by the finished product and the current regulatory framework.

Pyrogens and endotoxins: the basic difference

A pyrogen is any substance that can cause a fever when it reaches the bloodstream. Bacterial endotoxin, a component of the outer membrane of Gram-negative bacteria, is the most common and most studied pyrogen, and it is the one that pharmaceutical testing usually targets. Endotoxins are heat stable, so they can survive processes that kill the bacteria themselves, which is why materials that will meet sterile or parenteral routes must be tested rather than assumed clean.

Why the requirement depends on the route of administration

The human body tolerates endotoxin very differently by route. The digestive tract is routinely exposed to endotoxin and normally handles it, which is why oral dosage forms such as capsules and tablets do not generally need pyrogen or endotoxin control. Endotoxin becomes a critical quality attribute only when a material or its extract can reach the bloodstream, tissues or other normally sterile sites, as in injectable products, parenteral formulations, vaccine or biologic stabilisation, and certain wound-care or tissue-contact applications.

When pyrogen or endotoxin control applies to gelatin

• Injectable or parenteral dosage forms - if gelatin appears in a formulation that is injected, the excipient must normally meet an endotoxin requirement set for that product.
• Vaccines and biologics - gelatin used as a stabiliser in products given by injection is controlled against the finished-product specification.
• Sterile and medical applications - certain tissue-contact, implantable or device-related uses may demand low-endotoxin material.
• Specialised non-gelling grades - hydrolysed or non-gelling gelatins for cell culture or similar uses are sometimes supplied as low-endotoxin grades, again only when the application requires it.

Conventional pharmaceutical gelatin for capsule shells, tablets and other oral solid dosage forms is not normally subject to endotoxin limits, because the finished product does not carry such a requirement.

Test methods commonly used

When an endotoxin test is required, the choice of method follows the current pharmacopoeia and the product monograph. The best-known approach is the Limulus amoebocyte lysate (LAL) test, which uses a lysate of horseshoe-crab blood cells and reacts to endotoxin with a measurable clotting or colour response. Recombinant Factor C assays and the monocyte activation test (MAT) are newer options, and the rabbit pyrogen test measures fever response directly rather than endotoxin alone. Results are normally expressed in endotoxin units, for example per gram or per milligram of material, according to the agreed specification.

What to look for on a COA

If your product genuinely needs a low-endotoxin gelatin, ask the supplier for a grade that is documented as low endotoxin and check that the certificate of analysis reports the endotoxin result with the method and the limit it was tested against. If your product is an oral capsule or tablet, do not assume that a food- or capsule-grade certificate needs an endotoxin line; conversely, do not assume that a capsule grade would be suitable for an injectable use. When in doubt, confirm the requirement with your regulatory or quality team before you specify the grade.

Related reading

For the wider picture, see how to read a pharmaceutical gelatin specification (COA) and what microbial limits apply to pharmaceutical gelatin.